Contact Us
Global Tubersol Market Report 2025

Tubersol Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Tuberculosis Screening, Diagnosis Of Active Tuberculosis, Diagnosis Of Latent Tuberculosis, Other Respiratory Diseases), By Formulation (Single-Dose Vials, Multi-Dose Vials), By Distribution Channel (Hospital And Clinics, Retail And Specialty Pharmacies, Online Sales), By End User (Adult, Geriatric, Pediatric)

Tubersol Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Tubersol Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Tubersol Market?

Tubersol is a purified protein derivative (PPD) solution used in tuberculin skin tests (TST) to diagnose tuberculosis (TB) infection. It is injected under the skin, and the reaction at the injection site indicates whether an individual has been exposed to Mycobacterium tuberculosis.

The main types of clinical indications in tubersol are tuberculosis screening, diagnosis of active tuberculosis, diagnosis of latent tuberculosis, and other respiratory diseases. Tuberculosis screening is the process of identifying individuals with latent or active TB infection through tests like the tuberculin skin test, blood assays, or chest X-rays to enable early detection and treatment. It is available in both single-dose and multi-dose vial formulations, and distributed through various channels such as hospitals and clinics, retail and specialty pharmacies, and online sales. It cater to various end users such as adult, geriatric, and pediatric.

Tubersol Market Size and growth rate 2025 to 2029: Graph

What Is The Tubersol Market Size 2025 And Growth Rate?

The tubersol market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing healthcare infrastructure, adoption of new diagnostic technologies, rising adoption of point-of-care testing, rising prevalence of infectious and chronic diseases, and growing focus on precision medicine.

What Is The Tubersol Market Growth Forecast?

The tubersol market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising tuberculosis prevalence, increased focus on latent TB diagnosis, global initiatives to eliminate tuberculosis, growing awareness of tuberculosis testing, and government immunization and screening programs. Major trends in the forecast period include advancements in diagnostic tools, advancements in molecular diagnostic methods, development of new diagnostic standards, ongoing investment in research and development, and advancements such as liquid biopsy techniques.

How Is The Tubersol Market Segmented?

The tubersol market covered in this report is segmented –

1) By Clinical Indication: Tuberculosis Screening; Diagnosis Of Active Tuberculosis; Diagnosis Of Latent Tuberculosis; Other Respiratory Diseases

2) By Formulation: Single-Dose Vials; Multi-Dose Vials

3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies; Online Sales

4) By End User: Adult; Geriatric; Pediatric

What Is Driving The Tubersol Market? Increasing Tuberculosis Prevalence Drives Growth In The Market

The increasing prevalence of tuberculosis is expected to propel the growth of the tubersol market going forward. Tuberculosis (TB) is a contagious bacterial infection caused by mycobacterium tuberculosis that primarily affects the lungs but can also impact other body parts. The increasing prevalence of tuberculosis can be attributed to factors such as co-infection with HIV/AIDS, drug resistance, globalization and migration, poor nutrition, crowded living conditions, limited access to healthcare, stigma, and poor ventilation. Tubersol is used in the tuberculin skin test (TST) to help detect latent tuberculosis infections by triggering an immune response to the purified protein derivative of the TB bacteria. For instance, in November 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022, the United States recorded 8,331 tuberculosis (TB) cases, marking a 5.9% increase in case count compared to 2021. Therefore, the increasing prevalence of tuberculosis drives growth in the tubersol market.

What Is Driving The Tubersol Market? Rising Government Initiatives For Tuberculosis Drive Growth In Market

The rising government initiative for tuberculosis is expected to propel the growth of the tubersol market going forward. Tuberculosis (TB) is a contagious and potentially serious infectious disease primarily caused by the bacterium Mycobacterium tuberculosis. It usually affects the lungs (pulmonary tuberculosis), but it can also spread to other parts of the body, including the kidneys, spine, and brain (extrapulmonary TB). The rising government initiatives for tuberculosis are due to increased funding, policy support, and collaborative efforts to enhance TB diagnosis, treatment, and prevention, contributing to more effective disease control and improved public health outcomes. Government initiatives for tuberculosis, such as enhanced screening programs, funding for TB control, and global partnerships, stimulate the tubersol by increasing the demand for TB testing and diagnostic solutions. For instance, in October 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2023, an annual investment of $22 billion is required for TB prevention, diagnosis, treatment, and care to achieve the global objectives set for 2027, with 80% of the funding expected to come from domestic sources. Therefore, the rising government initiative for tuberculosis drives growth in the tubersol market.

What Is Driving The Tubersol Market? Development Of Healthcare Infrastructure Driving Growth In The Market

The development of healthcare infrastructure is expected to propel the growth of the tubersol market going forward. Healthcare infrastructure is the facilities, equipment, goods, and systems that support delivering healthcare services, ensuring effective and accessible medical care for individuals and communities. The development of healthcare infrastructure is due to advancing medical technologies, increasing healthcare demands, and government initiatives, leading to greater investments in modern facilities and improved healthcare access globally. Healthcare infrastructure drives the adoption of Tubersol by ensuring widespread availability, supporting skilled administration, and facilitating efficient distribution and integration into national TB control efforts. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from the previous year when there were 6,093 hospitals. Therefore, developing healthcare infrastructure is driving growth in the tubersol market.

Who Are The Major Players In The Global Tubersol Market?

Major companies operating in the tubersol market are Sanofi S.A.

Regional Analysis For The Global Tubersol Market

North America was the largest region in the tubersol market in 2024. The regions covered in the tubersol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tubersol market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Tubersol Market?

The tubersol market consists of sales of syringes and needles, diagnostic reagents, refrigeration storage units, multi-dose vials, and purified protein derivative (PPD) injections. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tubersol Industry?

The tubersol market research report is one of a series of new reports from The Business Research Company that provides tubersol market statistics, including the tubersol industry global market size, regional shares, competitors with the tubersol market share, detailed tubersol market segments, market trends, and opportunities, and any further data you may need to thrive in the tubersol industry. This tubersol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Tubersol Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The tubersol market covered in this report is segmented –
1) By Clinical Indication: Tuberculosis Screening; Diagnosis Of Active Tuberculosis; Diagnosis Of Latent Tuberculosis; Other Respiratory Diseases
2) By Formulation: Single-Dose Vials; Multi-Dose Vials
3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies; Online Sales
4) By End User: Adult; Geriatric; Pediatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi S.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Tubersol Market Characteristics

    3. Tubersol Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Tubersol Market Trends And Strategies

    5. Tubersol Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    6. Global Tubersol Growth Analysis And Strategic Analysis Framework

    6.1. Global Tubersol PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Tubersol Market Growth Rate Analysis

    6.4. Global Tubersol Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Tubersol Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Tubersol Total Addressable Market (TAM)

    7. Global Tubersol Pricing Analysis & Forecasts

    8. Tubersol Market Segmentation

    8.1. Global Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Tuberculosis Screening

    Diagnosis Of Active Tuberculosis

    Diagnosis Of Latent Tuberculosis

    Other Respiratory Diseases

    8.2. Global Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Single-Dose Vials

    Multi-Dose Vials

    8.3. Global Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital And Clinics

    Retail And Specialty Pharmacies

    Online Sales

    8.4. Global Tubersol Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult

    Geriatric

    Pediatric

    9. Global Tubersol Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Tubersol Market Regional And Country Analysis

    10.1. Global Tubersol Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Tubersol Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Tubersol Market

    11.1. Asia-Pacific Tubersol Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Tubersol Market

    12.1. China Tubersol Market Overview

    12.2. China Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Tubersol Market

    13.1. India Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Tubersol Market

    14.1. Japan Tubersol Market Overview

    14.2. Japan Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Tubersol Market

    15.1. Australia Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Tubersol Market

    16.1. South Korea Tubersol Market Overview

    16.2. South Korea Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Tubersol Market

    17.1. Western Europe Tubersol Market Overview

    17.2. Western Europe Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Tubersol Market

    18.1. UK Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Tubersol Market

    19.1. Germany Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Tubersol Market

    20.1. France Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Tubersol Market

    21.1. Eastern Europe Tubersol Market Overview

    21.2. Eastern Europe Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Tubersol Market

    22.1. North America Tubersol Market Overview

    22.2. North America Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Tubersol Market

    23.1. USA Tubersol Market Overview

    23.2. USA Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Tubersol Market

    24.1. Canada Tubersol Market Overview

    24.2. Canada Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Tubersol Market

    25.1. South America Tubersol Market Overview

    25.2. South America Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Tubersol Market

    26.1. Middle East Tubersol Market Overview

    26.2. Middle East Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Tubersol Market

    27.1. Africa Tubersol Market Overview

    27.2. Africa Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Tubersol Market Competitive Landscape And Company Profiles

    28.1. Tubersol Market Competitive Landscape

    28.2. Tubersol Market Company Profiles

    28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Tubersol Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Tubersol Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Tubersol Market

    32. Recent Developments In The Tubersol Market

    33. Tubersol Market High Potential Countries, Segments and Strategies

    33.1 Tubersol Market In 2029 - Countries Offering Most New Opportunities

    33.2 Tubersol Market In 2029 - Segments Offering Most New Opportunities

    33.3 Tubersol Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Tubersol Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Tubersol Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Tubersol Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Sanofi S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Tubersol Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Tubersol Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Tubersol Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Tubersol Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Tubersol Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Tubersol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Sanofi S.A. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Tubersol market?

Tubersol is a purified protein derivative (PPD) solution used in tuberculin skin tests (TST) to diagnose tuberculosis (TB) infection. It is injected under the skin, and the reaction at the injection site indicates whether an individual has been exposed to Mycobacterium tuberculosis. For further insights on the Tubersol market, request a sample here

How will the Tubersol market drivers and restraints affect the market dynamics? What forces will shape the Tubersol industry going forward?

The Tubersol market major growth driver - Increasing Tuberculosis Prevalence Drives Growth In The Market. For further insights on the Tubersol market, request a sample here

What is the forecast market size or the forecast market value of the Tubersol market?

The Tubersol market size has grown strongly in recent years. The tubersol market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing healthcare infrastructure, adoption of new diagnostic technologies, rising adoption of point-of-care testing, rising prevalence of infectious and chronic diseases, and growing focus on precision medicine. The tubersol market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising tuberculosis prevalence, increased focus on latent TB diagnosis, global initiatives to eliminate tuberculosis, growing awareness of tuberculosis testing, and government immunization and screening programs. Major trends in the forecast period include advancements in diagnostic tools, advancements in molecular diagnostic methods, development of new diagnostic standards, ongoing investment in research and development, and advancements such as liquid biopsy techniques. For further insights on the Tubersol market, request a sample here

How is the Tubersol market segmented?

The tubersol market covered in this report is segmented –
1) By Clinical Indication: Tuberculosis Screening; Diagnosis Of Active Tuberculosis; Diagnosis Of Latent Tuberculosis; Other Respiratory Diseases
2) By Formulation: Single-Dose Vials; Multi-Dose Vials
3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies; Online Sales
4) By End User: Adult; Geriatric; Pediatric For further insights on the Tubersol market,
request a sample here

Which region has the largest share of the Tubersol market? What are the other regions covered in the report?

North America was the largest region in the tubersol market in 2024. The regions covered in the tubersol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Tubersol market, request a sample here.

Who are the major players in the Tubersol market?

Major companies operating in the tubersol market are Sanofi S.A. . For further insights on the Tubersol market, request a sample here.

What are the key trends in the Tubersol market?

Major trends in the Tubersol market include . For further insights on the Tubersol market, request a sample here.

What are the major opportunities in the Tubersol market? What are the strategies for the Tubersol market?

For detailed insights on the major opportunities and strategies in the Tubersol market, request a sample here.

How does the Tubersol market relate to the overall economy and other similar markets?

For detailed insights on Tubersol's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Tubersol industry?

For detailed insights on the mergers and acquisitions in the Tubersol industry, request a sample here.

What are the key dynamics influencing the Tubersol market growth? SWOT analysis of the Tubersol market.

For detailed insights on the key dynamics influencing the Tubersol market growth and SWOT analysis of the Tubersol industry, request a sample here.